Daniel Brian Nichols

Design of a SARS-CoV-2 papain-like protease inhibitor with antiviral efficacy in a mouse model

Nirmatrelvir for Vaccinated or Unvaccinated Adult Outpatients with Covid-19

Severe Acute Respiratory Syndrome Coronavirus Papain-like Novel Protease Inhibitors: Design, Synthesis, Protein−Ligand X-ray Structure and Biological Evaluation

Structure-Based Design, Synthesis, and Biological Evaluation of a Series of Novel and Reversible Inhibitors for the Severe Acute Respiratory Syndrome−Coronavirus Papain-Like Protease